# LO LOESTRIN FE
> **NDA022501** · New Drug Application · Sponsor: APIL · Approved 2010-10-21
## Drug
- **FDA Application Number:** NDA022501
- **Application type:** New Drug Application
- **Brand name:** LO LOESTRIN FE
- **Generic name:** NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APIL
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2010-10-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022501)
---
*AI Analytics · CC0 1.0*